Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening

Stem Cells and Development

Volumn 23, Issue 3, 2014, Pages 245-261

  Ghosh, Deepraj ^a   Lili, Loukia ^b   McGrail, Daniel J ^a   Matyunina, Lilya V ^b   McDonald, John F ^b   Dawson, Michelle R ^a,b  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; F ACTIN; GROWTH INHIBITOR; INTEGRIN; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ELONGATION; CELL FUNCTION; CONTROLLED STUDY; CYTOSKELETON; FLOW KINETICS; GENETIC ASSOCIATION; MALE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MICROTUBULE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULUS; STRESS FIBER; UPREGULATION; YOUNG MODULUS;

ANIMALS; BENZODIOXOLES; BIOMECHANICAL PHENOMENA; BONE MARROW CELLS; CELL ADHESION; CELL PROLIFERATION; DRUG SYNERGISM; ELASTIC MODULUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMIDAZOLES; INDANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET-DERIVED GROWTH FACTOR; PRIMARY CELL CULTURE; PYRAZOLES; PYRIDINES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84893044005     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0240     Document Type: Article

References (107)

1. Caplan AI. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347
2. Caplan AI and SP Bruder. (2001). Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264
3. da Silva Meirelles L, PC. Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213
4. Pittenger MF, AM. Mackay, SC. Beck, RK. Jaiswal, R. Douglas, JD. Mosca, MA. Moorman, DW. Simonetti, S. Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
5. Phinney DG and DJ Prockop. (2007). Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25:2896-2902
6. Chamberlain G, J. Fox, B. Ashton and J Middleton. (2007). Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749
7. Parekkadan B and JM Milwid. (2010). Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87-117
8. Williams AR and JM Hare. (2011). Mesenchymal stem cells biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109: 923-940
9. Lee RH, MJ. Seo, RL. Reger, JL. Spees, AA. Pulin, SD. Olson and DJ Prockop. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 103:17438-17443
10. Németh K, A. Leelahavanichkul, PS. Yuen, B. Mayer, A. Parmelee, K. Doi, PG. Robey, K. Leelahavanichkul, BH. Koller and JM Brown. (2008). Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49
11. Gupta N, X. Su, B. Popov, JW. Lee, V. Serikov and MA Matthay. (2007). Intrapulmonary delivery of bone marrowderived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:1855-1863
12. Wu Y, J. Wang, PG. Scott and EE Tredget. (2007). Bone marrow-derived stem cells in wound healing: A review. Wound Repair Regen 15:S18-S26
13. Maxson S, EA. Lopez, D. Yoo, A. Danilkovitch-Miagkova and MA LeRoux. (2012). Concise review: Role of mesenchymal stem cells in wound repair. Stem Cells Transl Med 1:142-149
14. Discher DE, DJ. Mooney and PW Zandstra. (2009). Growth factors, matrices, and forces combine and control stem cells. Science 324:1673-1677
15. McBeath R, DM. Pirone, CM. Nelson, K. Bhadriraju and CS Chen. (2004). Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6:483-495
16. Engler A, S. Sen, H. Sweeney and D Discher. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126:677-689
17. Wang L, Y. Li, X. Chen, J. Chen, S. Gautam, Y. Xu and M Chopp. (2002). MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7:113-117
18. Ji JF, BP. He, ST. Dheen and SSW Tay. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-427
19. McGrail DJ, D. Ghosh, ND. Quach and MR Dawson. (2012). Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors. PloS One 7:e33248
20. Kole TP, Y. Tseng, I. Jiang, JL. Katz and D Wirtz. (2005). Intracellular mechanics of migrating fibroblasts. Mol Biol Cell 16:328-338
21. McGrail DJ, KM. McAndrews and MR Dawson. (2012). Biomechanical analysis predicts decreased human mesenchymal stem cell function before molecular differences. Exp Cell Res 319:684-696
22. Klopp AH, EL. Spaeth, JL. Dembinski, WA. Woodward, A. Munshi, RE. Meyn, JD. Cox, M. Andreeff and FC Marini. (2007). Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67:11687-11695
23. Birnbaum T, J. Roider, C. Schankin, C. Padovan, C. Schichor, R. Goldbrunner and A Straube. (2007). Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 83:241-247
24. Dittmar T and F Entschladen. (2013). Migratory properties of mesenchymal stem cells. In: Mesenchymal Stem Cells-Basics and Clinical Application I. Weyand B, M. Dominici, R. Hass, R. Jacobs and C Kasper, eds. Springer Berlin Heidelberg, pp 117-136
25. Derynck R and K Miyazono. (2008). The TGF-[beta] family. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
26. Massagué J. (1998). TGF-b signal transduction. Annu Rev Biochem 67:753-791
27. Derynck R and YE Zhang. (2003). Smad-dependent and Smad-independent pathways in TGF-b family signalling. Nature 425:577-584
28. Crowe MJ, T. Doetschman and DG Greenhalgh. (2000). Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 115:3-11
29. Hanahan D and RA Weinberg. (2000). The hallmarks of cancer. Cell 100:57-70
30. Moustakas A, K. Pardali, A. Gaal and CH Heldin. (2002). Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 82:85-91
31. Margadant C and A Sonnenberg. (2010). Integrin-TGF-b crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11:97-105
32. Epstein FH, GC. Blobe, WP. Schiemann and HF Lodish. (2000). Role of transforming growth factor b in human disease. N Engl J Med 342:1350-1358
33. Leight JL, MA. Wozniak, S. Chen, ML. Lynch and CS Chen. (2012). Matrix rigidity regulates a switch between TGFbeta1-induced apoptosis and epithelial-mesenchymal transition. Mol Biol Cell 23:781-791
34. Orimo A and RA Weinberg. (2006). Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 5: 1597-1601
35. Chen Wand SM Wahl. (1999). Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect 1:1367-1380
36. Yingling JM, KL. Blanchard and JS Sawyer. (2004). Development of TGF-b signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3:1011-1022
37. Ponte AL, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord and J Domenech. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-1745
38. Fiedler J, G. Rö derer, KP. Gü nther and RE Brenner. (2002). BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87:305-312
39. Andrae J, R. Gallini and C Betsholtz. (2008). Role of plateletderived growth factors in physiology and medicine. Genes Dev 22:1276-1312
40. Betsholtz C, L. Karlsson and P Lindahl. (2001). Developmental roles of platelet-derived growth factors. BioEssays 23:494-507
41. Betsholtz C. (2004). Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15:215-228
42. Ball SG, CA. Shuttleworth and CM Kielty. (2007). Plateletderived growth factor receptor-[alpha] is a key determinant of smooth muscle [alpha]-Actin filaments in bone marrowderived mesenchymal stem cells. Int J Biochem Cell Biol 39:379-391
43. Jechlinger M, A. Sommer, R. Moriggl, P. Seither, N. Kraut, P. Capodiecci, M. Donovan, C. Cordon-Cardo, H. Beug and S Grü nert. (2006). Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 116:1561-1570
44. Kole TP, Y. Tseng and D Wirtz. (2004). Intracellular microrheology as a tool for the measurement of the local mechanical properties of live cells. Methods Cell Biol 78:45-64
45. Tseng Y, E. Fedorov, JM. McCaffery, SC. Almo and D Wirtz. (2001). Micromechanics and ultrastructure of actin filament networks crosslinked by human fascin: A comparison with alpha-Actinin. J Mol Biol 310:351-366
46. Engler AJ, MA. Griffin, S. Sen, CG. Bonnemann, HL. Sweeney and DE Discher. (2004). Myotubes differentiate optimally on substrates with tissue-like stiffness: Pathological implications for soft or stiff microenvironments. J Cell Biol 166:877-887
47. Kole TP, Y. Tseng, L. Huang, JL. Katz and D Wirtz. (2004). Rho kinase regulates the intracellular micromechanical response of adherent cells to rho activation. Mol Biol Cell 15:3475-3484
48. Wirtz D. (2009). Particle-Tracking microrheology of living cells: Principles and applications. Annu Rev Biophys 38:301-326
49. Treiser MD, EH. Yang, S. Gordonov, DM. Cohen, IP. Androulakis, J. Kohn, CS. Chen and PV Moghe. (2010). Cytoskeleton-based forecasting of stem cell lineage fates. Proc Natl Acad Sci U S A 107:610-615
50. Kilian KA, B. Bugarija, BT. Lahn and M Mrksich. (2010). Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci U S A 107:4872-4877
51. Winder SJ and KR Ayscough. (2005). Actin-binding proteins. J Cell Sci 118:651-654
52. Sun Y, CS. Chen and J Fu. (2012). Forcing stem cells to behave: A biophysical perspective of the cellular microenvironment. Annu Rev Biophys 41:519-542
53. Pullarkat PA, PA. Fernández and A Ott. (2007). Rheological properties of the eukaryotic cell cytoskeleton. Phys Rep 449:29-53
54. Byfield FJ, RK. Reen, T-P Shentu, I. Levitan and KJ Gooch. (2009). Endothelial actin and cell stiffness is modulated by substrate stiffness in 2D and 3D. J Biomech 42:1114-1119
55. Darling EM, M. Topel, S. Zauscher, TP. Vail and F Guilak. (2008). Viscoelastic properties of human mesenchymallyderived stem cells and primary osteoblasts, chondrocytes, and adipocytes. J Biomech 41:454-464
56. Pang C, Z. Gao, J. Yin, J. Zhang, W. Jia and J Ye. (2008). Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab 295:E313-E322
57. Leitzel K, W. Bryce, J. Tomita, G. Manderino, I. Tribby, A. Thomason, M. Billingsley, E. Podczaski, H. Harvey and M Bartholomew. (1991). Elevated plasma platelet-derived growth factor B-chain levels in cancer patients. Cancer Res 51:4149-4154
58. Hudkins KL, DG. Gilbertson, M. Carling, S. Taneda, SD. Hughes, MS. Holdren, TE. Palmer, S. Topouzis, AC. Haran and AL Feldhaus. (2004). Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 15:286-298
59. Meyer A, W. Wang, J. Qu, L. Croft, JL. Degen, BS. Coller and J Ahamed. (2012). Platelet TGF-b1 contributions to plasma TGF-b1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood 119:1064-1074
60. Wakefield LM, JJ. Letterio, T. Chen, D. Danielpour, RS. Allison, LH. Pai, AM. Denicoff, MH. Noone, KH. Cowan and JA O'Shaughnessy. (1995). Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1:129-136
61. Kortesidis A, A. Zannettino, S. Isenmann, S. Shi, T. Lapidot and S Gronthos. (2005). Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105:3793-3801
62. Cassiede P, JE. Dennis, F. Ma and AI Caplan. (1996). Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-b1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 11:1264-1273
63. Tang Y, X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, TR. Nagy, X. Peng and J Hu. (2009). TGF-b1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15:757-765
64. Hellingman CA, ENB Davidson, W. Koevoet, EL. Vitters, WB. van den Berg, GJ. van Osch and PM van der Kraan. (2011). Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: Inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 17:1157-1167
65. Fujitani M, N. Grinshtein, KM. Smith and DR Kaplan. (2012). Potent and selective cytotoxic and cytostatic activity of JNJ-10198409 against neuroblastoma cells. Chiba Med J 88:27-34
66. D'Andrea MR, JM. Mei, RW. Tuman, RA. Galemmo and DL Johnson. (2005). Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis. Mol Cancer Therapeut 4:1198-1204
67. Tee S-Y, J. Fu, CS. Chen and PA Janmey. (2011). Cell shape and substrate rigidity both regulate cell stiffness. Biophys J 100:L25-L27
68. DaCosta Byfield S, C. Major, NJ. Laping and AB Roberts. (2004). SB-505124 is a selective inhibitor of transforming growth factor-b type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65:744-752
69. Ho CY, DW. Ludovici, US. Maharoof, J. Mei, JL. Sechler, RW. Tuman, ED. Strobel, L. Andraka, H-K Yen and G Leo. (2005). (6, 7-Dimethoxy-2, 4-dihydroindeno [1, 2-c] pyrazol-3-yl) phenylamines: Platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells. J Med Chem 48:8163-8173
70. Tusher VG, R. Tibshirani and G Chu. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116-5121
71. Uribe R and D Jay. (2009). A review of actin binding proteins: New perspectives. Mol Biol Rep 36:121-125
72. Subramanian A, P. Tamayo, VK. Mootha, S. Mukherjee, BL. Ebert, MA. Gillette, A. Paulovich, SL. Pomeroy, TR. Golub, ES. Lander and JP Mesirov. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genomewide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550
73. Haynes J, J. Srivastava, N. Madson, T. Wittmann and DL Barber. (2011). Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol Biol Cell 22:4750-4764
74. Djouad F, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noel and C Jorgensen. (2003). Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844
75. Barrientos S, O. Stojadinovic, MS. Golinko, H. Brem and M Tomic-Canic. (2008). Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601
76. Hanahan D and RA Weinberg. (2011). Hallmarks of cancer: The next generation. Cell 144:646-674
77. Esue O, Y. Tseng and D Wirtz. (2009). a-Actinin and filamin cooperatively enhance the stiffness of actin filament networks. PLoS One 4:e4411
78. Xu J, D. Wirtz and TD Pollard. (1998). Dynamic crosslinking by a-Actinin determines the mechanical properties of actin filament networks. J Biol Chem 273:9570-9576
79. Tseng Y, TP. Kole, JS. Lee, E. Fedorov, SC. Almo, BW. Schafer and D Wirtz. (2005). How actin crosslinking and bundling proteins cooperate to generate an enhanced cell mechanical response. Biochem Biophys Res Commun 334:183-192
80. Gonza'lez-Cruz RD, VC. Fonseca and EM Darling. (2012). Cellular mechanical properties reflect the differentiation potential of adipose-derived mesenchymal stem cells. Proc Natl Acad Sci U S A 109:E1523-E1529
81. Guck J, S. Schinkinger, B. Lincoln, F. Wottawah, S. Ebert, M. Romeyke, D. Lenz, HM. Erickson, R. Ananthakrishnan and D Mitchell. (2005). Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J 88:3689-3698
82. Pohlers D, J. Brenmoehl, I. Lö ffler, CK. Mü ller, C. Leipner, S. Schultze-Mosgau, A. Stallmach, RW. Kinne and G Wolf. (2009). TGF-b and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 1792:746-756
83. Warstat K, D. Meckbach, M. Weis-Klemm, A. Hack, G. Klein, P. de Zwart and WK Aicher. (2010). TGF-beta enhances the integrin alpha2beta1-mediated attachment of mesenchymal stem cells to type I collagen. Stem Cells Dev 19:645-656
84. D'Angelo M, JM. Chen, K. Ugen and RM Greene. (1994). TGF beta 1 regulation of collagen metabolism by embryonic palate mesenchymal cells. J Exp Zool 270:189-201
85. Xia C, XY. Yang, Y. Wang and S Tian. (2011). Inhibition effect of mannose-6-phosphate on expression of transforming growth factor Beta receptor in flexor tendon cells. Orthopedics 34:21
86. Zhang Z, TM. Garron, XJ. Li, Y. Liu, X. Zhang, YY. Li and WS Xu. (2009). Recombinant human decorin inhibits TGFbeta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns 35:527-537
87. Lu L, AS. Saulis, WR. Liu, NK. Roy, JD. Chao, S. Ledbetter and TA Mustoe. (2005). The temporal effects of anti-TGFbeta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201:391-397
88. Park JS, JS. Chu, AD. Tsou, R. Diop, Z. Tang, A. Wang and S Li. (2011). The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-beta. Biomaterials 32:3921-3930
89. Zhao F, YF. Zhang, YG. Liu, JJ. Zhou, ZK. Li, CG. Wu and HW Qi. (2008). Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc 40:1700-1705
90. Ng F, S. Boucher, S. Koh, KS. Sastry, L. Chase, U. Lakshmipathy, C. Choong, Z. Yang, MC. Vemuri, MS. Rao and V Tanavde. (2008). PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112:295-307
91. Edlund S, M. Landstrom, C-H Heldin and P Aspenstrom. (2002). Transforming Growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by Small GTPases Cdc42 and RhoA. Mol Biol Cell 13:902-914
92. Vardouli L, E. Vasilaki, E. Papadimitriou, D. Kardassis and C Stournaras. (2008). A novel mechanism of TGFb-induced actin reorganization mediated by Smad proteins and Rho GTPases. FEBS J 275:4074-4087
93. Arber S, FA. Barbayannis, H. Hanser, C. Schneider, CA. Stanyon, O. Bernard and P Caroni. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIMkinase. Nature 393:805-809
94. Wachsstock DH, W. Schwartz and TD Pollard. (1993). Affinity of alpha-Actinin for actin determines the structure and mechanical properties of actin filament gels. Biophys J 65:205-214
95. Tojkander S, G. Gateva and P Lappalainen. (2012). Actin stress fibers-Assembly, dynamics and biological roles. J Cell Sci 125:1855-1864
96. Goodman A, BL. Goode, P. Matsudaira and GR Fink. (2003). The Saccharomyces cerevisiae calponin/transgelin homolog Scp1 functions with fimbrin to regulate stability and organization of the actin cytoskeleton. Mol Biol Cell 14:2617-2629
97. Vignjevic D, S-i Kojima, Y. Aratyn, O. Danciu, T. Svitkina and GG Borisy. (2006). Role of fascin in filopodial protrusion. J Cell Biol 174:863-875
98. Discher DE, P. Janmey and Y-l Wang. (2005). Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139-1143
99. Qi Y-X, J. Jiang, X-H Jiang, X-D Wang, S-Y Ji, Y. Han, D-K Long, B-R Shen, Z-Q Yan and S Chien. (2011). PDGF-BB and TGF-b1 on cross-Talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress. Proc Natl Acad Sci U S A 108:1908-1913
100. Leof EB, JA. Proper, AS. Goustin, GD. Shipley, PE. DiCorleto and HL Moses. (1986). Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: A proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A 83:2453-2457
101. Wan M, C. Li, G. Zhen, K. Jiao, W. He, X. Jia, W. Wang, C. Shi, Q. Xing and YF Chen. (2012). Injury-Activated transforming growth factor b controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 30:2498-2511
102. Kim Y, MI. Fiel, E. Albanis, HI. Chou, W. Zhang, G. Khitrov and SL Friedman. (2012). Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate. Liver Int 32:1008-1017
103. Biswas S, TL. Criswell, SE. Wang and CL Arteaga. (2006). Inhibition of transforming growth factor-b signaling in human cancer: Targeting a tumor suppressor network as a therapeutic strategy. Clin Cancer Res 12:4142-4146
104. Gotzmann J, A. Fischer, M. Zojer, M. Mikula, V. Proell, H. Huber, M. Jechlinger, T. Waerner, A. Weith and H Beug. (2006). A crucial function of PDGF in TGF-b-mediated cancer progression of hepatocytes. Oncogene 25:3170-3185
105. Battegay EJ, EW. Raines, RA. Seifert, DF. Bowen-Pope and R Ross. (1990). TGF-b induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524
106. Klass B, A. Grobbelaar and K Rolfe. (2009). Transforming growth factor b1 signalling, wound healing and repair: A multifunctional cytokine with clinical implications for wound repair, a. delicate balance. Postgrad Med J 85:9-14
107. Zavadil J and EP Bö ttinger. (2005). TGF-b and epithelial- Tomesenchymal transitions. Oncogene 24:5764-5774